OncoPrecision

OncoPrecision is a biotechnology company focused on AI-driven precision oncology. Founded in late 2020 by a team of experts, including Dr. Gastón Soria, the company is based in New York and aims to improve drug development success rates by utilizing patient-derived models and high-throughput biology. The company combines patient-derived cells with advanced screening techniques to recreate tumor microenvironments, allowing for rapid testing of drug candidates. OncoPrecision employs machine learning to analyze single-cell data, predict drug responses, and optimize therapeutic candidates. It collaborates with major pharmaceutical companies for target discovery and drug development, and is developing antibody-drug conjugates and bispecific antibodies targeting various cancers. The company is also conducting clinical studies with cancer centers to validate its innovative approaches.